SYK – Stryker Corporation
Stryker CorporationSYK
$383.42Name : Stryker Corporation
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $146,165,841,920.00
EPSttm : 9.32
Stryker Corporation
$383.42
0.43%$1.63Float Short %
1.29
Margin Of Safety %
Put/Call OI Ratio
1.04
EPS Next Q Diff
-0.01
EPS Last/This Y
1.46
EPS This/Next Y
1.41
Price
383.52
Target Price
414.5
Analyst Recom
1.88
Performance Q
6.12
Relative Volume
1.34
Beta
0.96
Ticker: SYK
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | SYK | 357.01 | 1.08 | 0.93 | 34758 |
| 2024-12-20 | SYK | 364.54 | 1.07 | 3.57 | 35091 |
| 2024-12-23 | SYK | 366.68 | 1.01 | 0.30 | 28387 |
| 2024-12-24 | SYK | 370.78 | 0.99 | 1.25 | 28726 |
| 2024-12-26 | SYK | 369.46 | 0.99 | 0.68 | 28723 |
| 2024-12-27 | SYK | 367.1 | 0.99 | 0.46 | 29121 |
| 2024-12-30 | SYK | 362.39 | 1.00 | 0.69 | 29246 |
| 2024-12-31 | SYK | 360.17 | 1.03 | 0.23 | 28766 |
| 2025-01-02 | SYK | 358.88 | 1.02 | 2.12 | 28813 |
| 2025-01-03 | SYK | 361.35 | 1.01 | 5.97 | 28979 |
| 2025-01-06 | SYK | 361.51 | 1.04 | 6.29 | 29502 |
| 2025-01-07 | SYK | 355.23 | 1.06 | 1.71 | 29943 |
| 2025-01-08 | SYK | 363.9 | 1.05 | 1.53 | 29648 |
| 2025-01-09 | SYK | 364.1 | 1.05 | 1.25 | 29648 |
| 2025-01-10 | SYK | 365.87 | 1.05 | 4.36 | 29908 |
| 2025-01-13 | SYK | 360.97 | 1.04 | 0.13 | 29996 |
| 2025-01-14 | SYK | 362.78 | 1.00 | 0.46 | 30505 |
| 2025-01-15 | SYK | 368.47 | 0.99 | 0.09 | 30788 |
| 2025-01-16 | SYK | 381.79 | 1.02 | 1.15 | 30571 |
| 2025-01-17 | SYK | 383.42 | 1.04 | 1.00 | 30949 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | SYK | 357.01 | 12.0 | 1290.5 | 12.06 |
| 2024-12-20 | SYK | 364.50 | 12.0 | 1431.2 | 12.06 |
| 2024-12-23 | SYK | 366.49 | 12.0 | 1349.7 | 12.06 |
| 2024-12-24 | SYK | 370.78 | 12.0 | 1384.3 | 12.06 |
| 2024-12-26 | SYK | 369.42 | 12.0 | 1302.9 | 12.06 |
| 2024-12-27 | SYK | 367.17 | 12.0 | 1290.0 | 12.06 |
| 2024-12-30 | SYK | 362.31 | 12.0 | 1253.0 | 12.06 |
| 2024-12-31 | SYK | 360.02 | 12.0 | 1301.9 | 12.06 |
| 2025-01-02 | SYK | 358.82 | 12.0 | 1316.5 | 12.06 |
| 2025-01-03 | SYK | 361.46 | 12.0 | 1375.0 | 12.06 |
| 2025-01-06 | SYK | 361.20 | 12.0 | 1317.6 | 12.06 |
| 2025-01-07 | SYK | 355.23 | 12.0 | 1232.5 | 12.06 |
| 2025-01-08 | SYK | 364.10 | 12.0 | 1455.0 | 12.06 |
| 2025-01-09 | SYK | 364.10 | 12.0 | 1322.3 | 12.06 |
| 2025-01-10 | SYK | 365.70 | 12.0 | 1345.5 | 12.06 |
| 2025-01-13 | SYK | 360.83 | 12.0 | 1252.3 | 12.06 |
| 2025-01-14 | SYK | 362.77 | 12.0 | 1348.5 | 12.06 |
| 2025-01-15 | SYK | 368.61 | 12.0 | 1407.0 | 12.06 |
| 2025-01-16 | SYK | 381.73 | 12.0 | 1510.8 | 12.06 |
| 2025-01-17 | SYK | 383.52 | 12.0 | 1346.3 | 12.06 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | SYK | -2.08 | 1.27 | 1.19 |
| 2024-12-20 | SYK | -2.08 | 1.27 | 1.19 |
| 2024-12-23 | SYK | -2.04 | 1.26 | 1.19 |
| 2024-12-24 | SYK | -2.04 | 1.26 | 1.19 |
| 2024-12-26 | SYK | -2.06 | 1.26 | 1.20 |
| 2024-12-27 | SYK | -2.08 | 1.26 | 1.20 |
| 2024-12-30 | SYK | -2.09 | 1.27 | 1.20 |
| 2024-12-31 | SYK | -2.09 | 1.27 | 1.20 |
| 2025-01-02 | SYK | -2.08 | 1.27 | 1.20 |
| 2025-01-03 | SYK | -2.08 | 1.27 | 1.20 |
| 2025-01-06 | SYK | -2.06 | 1.27 | 1.20 |
| 2025-01-07 | SYK | -2.06 | 1.27 | 1.20 |
| 2025-01-08 | SYK | -2.08 | 1.27 | 1.20 |
| 2025-01-09 | SYK | -2.08 | 1.27 | 1.20 |
| 2025-01-10 | SYK | -2.08 | 1.27 | 1.20 |
| 2025-01-13 | SYK | -2.08 | 1.31 | 1.29 |
| 2025-01-14 | SYK | -2.08 | 1.31 | 1.29 |
| 2025-01-15 | SYK | -2.08 | 1.31 | 1.29 |
| 2025-01-16 | SYK | -2.08 | 1.31 | 1.29 |
| 2025-01-17 | SYK | -2.08 | 1.31 | 1.29 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.87
Avg. EPS Est. Current Quarter
3.87
Avg. EPS Est. Next Quarter
2.86
Insider Transactions
-2.08
Institutional Transactions
1.31
Beta
0.96
Average Sales Estimate Current Quarter
6361
Average Sales Estimate Next Quarter
5697
Fair Value
382
Quality Score
65
Growth Score
95
Sentiment Score
87
Actual DrawDown %
3.7
Max Drawdown 5-Year %
-43.8
Target Price
414.5
P/E
41.11
Forward P/E
28.4
PEG
3.88
P/S
6.65
P/B
7.25
P/Free Cash Flow
45.61
EPS
9.33
Average EPS Est. Cur. Y
12.06
EPS Next Y. (Est.)
13.47
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
16.34
Relative Volume
1.34
Return on Equity vs Sector %
-1.3
Return on Equity vs Industry %
5.2
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
1346.3
Stryker CorporationSector: Healthcare
Industry: Medical Devices
Employees: 52000
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
stock quote shares SYK – Stryker Corporation Stock Price stock today
news today SYK – Stryker Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch SYK – Stryker Corporation yahoo finance google finance
stock history SYK – Stryker Corporation invest stock market
stock prices SYK premarket after hours
ticker SYK fair value insiders trading